Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 3 | 1489 | 75 | 0.4483 | 0.9268 | 0.0504 | 0.0478 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 3244 | 144 | 0.9829 | 0.9268 | 0.0444 | 0.0478 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 4472 | 217 | 1.3491 | 0.9268 | 0.0485 | 0.0478 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 2 | 2653 | 123 | 0.7299 | 0.6853 | 0.0464 | 0.0479 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 3 | 2777 | 121 | 0.7662 | 0.6853 | 0.0436 | 0.0479 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 1 | 2050 | 110 | 0.5597 | 0.6853 | 0.0537 | 0.0479 |
A-375 | Vemurafenib | I-BET151 | 0.100 | 1.000 | uM | 72 | hr | 2 | 4119 | 181 | 0.2846 | 0.2971 | 0.0439 | 0.0480 |
A-375 | Vemurafenib | I-BET151 | 0.100 | 1.000 | uM | 72 | hr | 1 | 4645 | 211 | 0.3205 | 0.2971 | 0.0454 | 0.0480 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 1 | 736 | 41 | 0.7037 | 0.8032 | 0.0557 | 0.0480 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 2 | 894 | 41 | 0.8637 | 0.8032 | 0.0459 | 0.0480 |
A-375 | Vemurafenib | I-BET151 | 0.100 | 1.000 | uM | 72 | hr | 3 | 4187 | 229 | 0.2861 | 0.2971 | 0.0547 | 0.0480 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 3 | 869 | 37 | 0.8424 | 0.8032 | 0.0426 | 0.0480 |
A-375 | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 3 | 2509 | 127 | 0.1296 | 0.1363 | 0.0506 | 0.0481 |
A-375 | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 2 | 2552 | 108 | 0.1329 | 0.1363 | 0.0423 | 0.0481 |
A-375 | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 1 | 2836 | 146 | 0.1463 | 0.1363 | 0.0515 | 0.0481 |
MZ7-mel | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1692 | 86 | 0.3230 | 0.2758 | 0.0508 | 0.0483 |
MZ7-mel | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 1482 | 62 | 0.2856 | 0.2758 | 0.0418 | 0.0483 |
MZ7-mel | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 1148 | 60 | 0.2188 | 0.2758 | 0.0523 | 0.0483 |
A-375 | Vemurafenib | I-BET | 0.100 | 1.000 | uM | 72 | hr | 3 | 3934 | 188 | 0.2747 | 0.3080 | 0.0478 | 0.0484 |
A-375 | Vemurafenib | I-BET | 0.100 | 1.000 | uM | 72 | hr | 2 | 4395 | 227 | 0.3057 | 0.3080 | 0.0516 | 0.0484 |
A-375 | Vemurafenib | I-BET | 0.100 | 1.000 | uM | 72 | hr | 1 | 4909 | 225 | 0.3435 | 0.3080 | 0.0458 | 0.0484 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 2714 | 123 | 0.8451 | 0.7294 | 0.0453 | 0.0484 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 1917 | 95 | 0.5943 | 0.7294 | 0.0496 | 0.0484 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 2418 | 122 | 0.7489 | 0.7294 | 0.0505 | 0.0484 |
A-375 | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 3 | 18973 | 930 | 0.9815 | 1.0000 | 0.0490 | 0.0485 |